RN Mobile Menu

Search form




A small randomized trial from Italy found that while zoledronic acid (Reclast) slows bone loss in osteoporosis, it may also slow bone formation. Perhaps combination therapy is required.

Test your skills about the diagnosis and treatment of osteoporosis in this brief quiz offered by Nancy Lane MD.

Women with higher uric acid levels around and after menopause show less bone loss. What could this mean?

In response to a study published in the journal Heart that suggested a link between calcium supplementation and an increased risk of heart attack, the National Osteoporosis Foundation stated that the findings are inconclusive and that more research is needed to better understand the potential relationship between calcium supplements and heart attack risk.

Recent years have witnessed tremendous advances in the field of orthopedic surgery, particularly in total joint arthroplasty.

Women who experience early menopause are almost twice as likely to have osteoporosis and are at greater risk for fracture and death than women who experience menopause later in life, according to results of a 34-year study conducted in Sweden.

The first generic versions of Boniva (ibandronate) tablets, a once-monthly product for managing or preventing osteoporosis in postmenopausal women, have received FDA approval.


Subscribe to Osteoporosis on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.